Organon (OGN) Current Taxes (2020 - 2026)
Organon (OGN) posted quarterly Current Taxes of $84.0 million for Q2 2026, down 56.7% year-over-year from $194.0 million in Q2 2025, and up 9.09% on a QoQ basis from $77.0 million in Q1 2026.
Organon (OGN) Current Taxes (2020 - 2026) Analysis & Trends
Organon has reported Current Taxes for 7 years, with the latest figure at $84.0 million in Q2 2026.
- Current Taxes for Q2 2026 came in at $84.0 million, down 56.7% year-over-year; the trailing twelve-month figure through Jun 2026 was $84.0 million (down 56.7% YoY), and the FY2025 annual result was $85.0 million, down 36.57% from the prior year.
- Current Taxes improved to $84.0 million in Q2 2026, from $77.0 million in the prior quarter.
- Over five years, Current Taxes peaked at $230.0 million in Q3 2024 and troughed at $77.0 million in Q1 2026.
- A 5-year average of $168.3 million and a median of $188.0 million in 2022 frame the typical range for Current Taxes.
- The widest annual swing landed in 2024, when Current Taxes jumped 42.86%; it then slumped 56.7% in 2026.
- A 5-year view of Current Taxes shows it stood at $184.0 million in 2022, then grew by 11.96% to $206.0 million in 2023, then plunged by 34.95% to $134.0 million in 2024, then sank by 36.57% to $85.0 million in 2025, then retreated by 1.18% to $84.0 million in 2026.
- Per Business Quant data, the three most recent Current Taxes figures were $84.0 million in Q2 2026, $77.0 million in Q1 2026, and $85.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.75 Bn | 633.00 Bn | 17.26 Bn | 1.05 Bn |
| 2 | AbbVie | 469.96 Bn | 463.39 Bn | 12.70 Bn | - |
| 3 | Merck | 376.93 Bn | 369.79 Bn | 12.21 Bn | 4.22 Bn |
| 4 | Novartis Ag | 303.25 Bn | 295.56 Bn | 11.24 Bn | 2.31 Bn |
| 5 | Astrazeneca | 257.53 Bn | 252.63 Bn | 12.86 Bn | 1.47 Bn |
| 6 | Amgen | 236.22 Bn | 222.23 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 182.19 Bn | 179.01 Bn | 6.22 Bn | - |
| 8 | Pfizer | 159.20 Bn | 147.50 Bn | 10.94 Bn | 653.00 Mn |
| 9 | Gsk | 106.27 Bn | 102.10 Bn | 8.24 Bn | -703.04 Mn |
| 10 | Organon | 3.61 Bn | 2.47 Bn | 847.00 Mn | 84.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 84.00 Mn |
| Mar 31, 2026 | 77.00 Mn |
| Dec 31, 2025 | 85.00 Mn |
| Sep 30, 2025 | 116.00 Mn |
| Jun 30, 2025 | 194.00 Mn |
| Mar 31, 2025 | 176.00 Mn |
| Dec 31, 2024 | 134.00 Mn |
| Sep 30, 2024 | 230.00 Mn |
| Jun 30, 2024 | 201.00 Mn |
| Mar 31, 2024 | 196.00 Mn |
| Dec 31, 2023 | 206.00 Mn |
| Sep 30, 2023 | 161.00 Mn |
| Jun 30, 2023 | 163.00 Mn |
| Mar 31, 2023 | 192.00 Mn |
| Dec 31, 2022 | 184.00 Mn |
| Sep 30, 2022 | 217.00 Mn |
| Jun 30, 2022 | 211.00 Mn |
| Mar 31, 2022 | 202.00 Mn |
| Dec 31, 2021 | 185.00 Mn |
| Sep 30, 2021 | 335.00 Mn |